
Disciplinary decisions issued December 6 – 12, 2025.
Thomas Hyrkiel2 min read

The broker-dealer’s conduct was found to violate Section 17(a)(2) of the Securities Act.
Vlada Gurvich3 min read

The SEC found fault with the firm for how it reported cardiovascular safety results to investors regarding its drug, Roxadustat.
Julie DiMauro3 min read

The SEC has recently closed three very different but equally brazen fraud cases, each a window into a distinct form of financial misconduct.
Vlada Gurvich3 min read

Elanco’s use of sales incentives created misleading impressions of customer demand, the SEC stated.
Alexander Barzacanos1 min read

Five SEC enforcement actions include allegations that some advisers’ recommendations were not in the best interest of clients.
Julie DiMauro2 min read

The four settlements come nearly one year after the SEC sued SolarWinds for misleading investors about its cybersecurity controls.
Alexander Barzacanos, Julie DiMauro3 min read

Charges filed against broker-dealer and parent company over access to confidential trading information.
Julie DiMauro3 min read